LATEST
外 Waitan Ludi Policy Terminal China industrial-policy monitor · updated 2026-11-10
view asAnalystMonitorPolicymakerBusinessLegal
← Documents · Graph

北京经济技术开发区生物技术和大健康产业局关于开展2025年度医疗器械研发奖励相关事项申报的通知

No document number
Radar: Medical devices (rank 13 of 16)

Programme histories

Reviewed thematic associations are separate from legal citations and do not confirm payment.

Country-interest evidence · pilot

Trade inferences use UN Comtrade, with China as reporter. Country connections indicate potential trade relevance, not measured harm, firm-level exposure or legal applicability. Inward measures concern exporters to China; competition with Chinese exports in third markets is not assessed.

Inspect implementing jurisdictions and partner evidence · 48 relationships

Australia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 272,149,773

Austria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 148,030,024

Belgium: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 31,292,163

Bulgaria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 8,460,666

Brazil: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 16,118,960

Barbados: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 11,004,211

Canada: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 93,440,082

Switzerland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 814,796,838

Costa Rica: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 679,629,844

Czech Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 107,859,223

Germany: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 3,068,403,281

Denmark: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 148,409,183

Dominican Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 189,707,073

Spain: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 20,630,348

Estonia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 1,105,508

Finland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 56,505,049

France: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 438,228,197

United Kingdom: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 240,078,423

Hong Kong, China: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 2,058,476

Hungary: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 20,502,653

Indonesia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 17,974,796

India: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 118,810,902

Ireland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 1,030,519,031

Iceland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 4,148,196

Israel: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 337,538,216

Italy: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 137,268,900

Japan: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 1,406,803,703

Korea, Rep.: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 569,417,891

Mexico: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 2,489,119,888

Malaysia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 321,662,041

Netherlands: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 335,717,521

Norway: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 12,416,162

New Zealand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 31,757,322

Pakistan: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 11,227,490

Philippines: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 11,418,343

Poland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 53,193,456

Romania: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 13,216,669

Russian Federation: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 3,332,959

Singapore: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 345,699,744

Slovak Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 2,612,769

Slovenia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 9,795,314

Sweden: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 115,016,138

Thailand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 109,823,049

Turkey: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 53,467,673

Chinese Taipei: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 126,165,825

United States: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 4,563,459,822

Vietnam: Trade-based inference; exporters to China; summed product trade > USD 1m; 2025 trade; broad sector headings; computed, not analyst-reviewed · intervention 75156 · recorded trade USD 484,186,890

Implementing jurisdiction: China · intervention 75156

Assessment states
  • Trade-based partners recorded

Measures

Capital grant
Provincial · origin: Chinese firms or production in China · locality: Local firms · CPC 481 · in force from 2026-03-06 · until 2026-03-27 · Keyword screen (unreviewed)
Implemented by China (special economic zone) · affects 47 partners (inferred from trade data, 2025 trade): United States, Germany, Mexico, Japan, Ireland, Switzerland …
以上产品首次取得注册证并落地生产的，再给予800万元资金支持。
Supports production in a place, so favours that place by rule.

Full text

各相关单位： 为贯彻落实《北京经济技术开发区促进医药健康产业高质量发展的若干意见》（京技管发〔2025〕9号）的工作要求，现开展2025年度医疗器械研发奖励相关事项申报工作，通知如下： 一、申报时间 自2026年3月6日至2026年3月27日期间通过北京市人民政府门户网站“政策兑现”栏目（https://zhengce.beijing.gov.cn）或经开区官网“政策兑现”栏目（zcdx.kfqgw.beijing.gov.cn）进入政策兑现综合服务平台，注册登录后进行项目申报。如未在规定时间内提交申请的，视为自动放弃。 二、申报详情 详见附件中《办事指南》或政策兑现综合服务平台“项目申报”页面。 三、联系方式 政策咨询： 经开区政务服务大厅“政策申报”窗口，联系电话：010-67857878转4；010-67857687，工作日上午9:00—12:00，下午1:30—5:00。 经开区生物技术和大健康产业局，联系电话：010-83508311，工作日上午9:00—12:00，下午2:00—6:00。 技术支持： 联系电话：010-83509638，工作日上午9:00—12:00，下午2:00—6:00。 北京经济技术开发区生物技术和大健康产业局 2025年3月5日

Attachments (2)

附件2：2025年度高端医疗器械研发奖励办事指南 docx
Original file · 20.9 KB
附件2 2025年度高端医疗器械研发奖励 办事指南 一、政策依据 《北京经济技术开发区关于促进医药健康产业高质量发展的若干意见》（京技管发〔2025〕9号）第四条，“支持高端医疗器械研发。对新取得医疗器械注册证的产品，并落地生产的，分级分类给予资金支持，单个企业每年支持额度不超过300万元。” 二、申报事项 2025年度高端医疗器械研发奖励 三、申报条件 （一）申报单位应从事第二类、第三类医疗器械研发生产，具有独立法人资格，在亦庄新城225平方公里范围内依法实际经营，近三年无重大行政处罚记录和刑事犯罪记录，未列入严重违法失信主体名单。 （二）申报单位的产品首次取得二类、三类医疗器械注册证，且在经开区内落地生产。 四、奖励内容及标准 （一）自2025年1月1日至2025年12月31日，对首次取得二类、三类医疗器械注册证的医疗器械产品（体外诊断试剂除外），并落地生产的，给予一次性资金支持50万元、100万元，单个企业每年支持额度不超过300万元。 （二）自2025年1月1日至2025年12月31日，对首次取得二类、三类医疗器械注册证的体外诊断试剂产品，并落地生产的，给予一次性资金支持5万元、10万元，单个企业每年支持额度不超过100万元。 五、申报材料及要求 1.2025年度高端医疗器械研发奖励申报表，在线填写； 2.企业营业执照，选取电子证照； 3.承诺书，下载模版填写，签字、加盖公章，彩色扫描上传； 4.银行账户信息，下载模板填写，加盖公章，彩色扫描上传； 5.医疗器械注册证，原件彩色扫描上传； 6.医疗器械生产许可证（正本），原件彩色扫描上传。 六、办理程序 （一）网上申报：通过北京市人民政府门户网站“政策兑现”栏目（https://zhengce.beijing.gov.cn）或经开区官网“政策兑现”栏目（zcdx.kfqgw.beijing.gov.cn）进入政策兑现综合服务平台，注册登录后进行项目申报。如未在规定时间内提交申请的，视为自动放弃。 （二）初审：经开区营商环境建设局对申报主体提交的材料进行完整性审查，材料不齐全或不符合要求的，告知申报主体补齐补正。 （三）审核：经开区生物技术与大健康产业局对申请材料进行实质审核。 （四）确定扶持结果：经开区生物技术和大健康产业局对审核通过的申报主体拟定兑现扶持奖励金额。 （五）公示：经开区生物技术与大健康产业局通过政策兑现综合服务平台对审核通过的申报主体进行公示。 （六）资金拨付：经公示无异议的，完成资金拨付。 七、主责部门 经开区生物技术与大健康产业局 八、受理窗口 北京经济技术开发区万源街4号政务服务大厅“政策申报”窗口。 九、申报时间 2026年3月6日至2026年3月27日 十、联系方式 政策咨询： 经开区政务服务大厅“政策申报”窗口，联系电话：010-67857878转4；010-67857687，工作日上午9:00—12:00，下午1:30—5:00。 经开区生物技术与大健康产业局，联系电话：010-83508311，工作日上午9:00—12:00，下午2:00—6:00。 技术支持： 联系电话：010-83509638，工作日上午9:00—12:00，下午2:00—6:00。 十一、收费标准 不收费 十二、特别说明 2025年度首次取得注册证产品，注册证编号应为：X械注准2025XXXXXXX。其中，体外诊断试剂产品分类编码40，注册证编号应为：X械注准2025X40XXXX。
附件1：2025年度创新医疗器械研发奖励办事指南 docx
Original file · 21.8 KB
附件1 2025年度创新医疗器械研发奖励 办事指南 一、政策依据 《北京经济技术开发区关于促进医药健康产业高质量发展的若干意见》（京技管发〔2025〕9号）第四条，“对进入国家创新医疗器械特别审查程序的高端医疗装备产品的研发生产企业，给予一次性支持资金300万元。以上产品首次取得注册证并落地生产的，再给予800万元资金支持。单个企业每年支持额度不超过3000万元。” 二、申报事项 2025年度创新医疗器械研发奖励 三、申报条件 （一）申报单位应从事第三类医疗器械研发生产，具有独立法人资格，在亦庄新城225平方公里范围内依法实际经营，近三年无重大行政处罚记录和刑事犯罪记录，未列入严重违法失信主体名单。 （二）申报单位的产品已进入国家药品监督管理局创新医疗器械特别审查申请审查结果公示。 四、奖励内容及标准 （一）自2025年1月1日至2025年12月31日，首次进入国家创新医疗器械特别审查申请审查结果公示的高端医疗装备产品，给予一次性奖励资金300万元。 （二）自2025年1月1日至2025年12月31日，已进入国家创新医疗器械特别审查申请审查结果公示的高端医疗装备产品，首次取得注册证并落地生产，给予一次性奖励资金800万元。 （三）单个企业每年支持额度不超过3000万元。 五、申报材料及要求 1.2025年度创新医疗器械研发奖励申报表，在线填写； 2.企业营业执照，选取电子证照； 3.承诺书，下载模版填写，签字、加盖公章，彩色扫描上传； 4.银行账户信息，下载模板填写，加盖公章，彩色扫描上传； 5.国家创新医疗器械特别审查申请审查结果公示，原件彩色扫描上传； 6.若申请产品为首次取得注册证并落地生产的，需提供医疗器械注册证和医疗器械生产许可证（正本），原件彩色扫描上传。 六、办理程序 （一）网上申报：通过北京市人民政府门户网站“政策兑现”栏目（https://zhengce.beijing.gov.cn）或经开区官网“政策兑现”栏目（zcdx.kfqgw.beijing.gov.cn）进入政策兑现综合服务平台，注册登录后进行项目申报。如未在规定时间内提交申请的，视为自动放弃。 （二）初审：经开区营商环境建设局对申报主体提交的材料进行完整性审查，材料不齐全或不符合要求的，告知申报主体补齐补正。 （三）审核：经开区生物技术与大健康产业局对申请材料进行实质审核。 （四）确定扶持结果：经开区生物技术和大健康产业局对审核通过的申报主体拟定兑现扶持奖励金额。 （五）公示：经开区生物技术与大健康产业局通过政策兑现综合服务平台对审核通过的申报主体进行公示。 （六）资金拨付：经公示无异议的，完成资金拨付。 七、主责部门 经开区生物技术与大健康产业局 八、受理窗口 北京经济技术开发区万源街4号政务服务大厅“政策申报”窗口。 九、申报时间 2026年3月6日至2026年3月27日 十、联系方式 政策咨询： 经开区政务服务大厅“政策申报”窗口，联系电话：010-67857878转4；010-67857687，工作日上午9:00—12:00，下午1:30—5:00。 经开区生物技术与大健康产业局，联系电话：010-83508311，工作日上午9:00—12:00，下午2:00—6:00。 技术支持： 联系电话：010-83509638，工作日上午9:00—12:00，下午2:00—6:00。 十一、收费标准 不收费 十二、特别说明 1.奖励以国家创新医疗器械特别审查申请审查结果公示为准，一个创新批件公示按照一个产品给予资金补贴。 2.已进入国家创新医疗器械特别审查申请审查结果公示，并于2025年1月1日至2025年12月31日首次取得三类医疗器械注册证并落地生产的高端医疗装备产品，一次性资金奖励与2025年度支持高端医疗器械研发奖励不予重复支持。
Attachment text is included when measures, dates, citations and tags are extracted.